In a study of over 17,000 people, semaglutide, a GLP-1 receptor agonist medication, was found to lower the risk of cardiovascular events like heart attacks and strokes by 20% in people who have pre-existing cardiovascular disease and who are overweight, but do not have Type 2 diabetes
J Environ Biol 33(2):201 Passaia G, Margis-Pinheiro M (2015) Glutathione peroxidases as redox sensor proteins in plant cells
Transferrin synthesis is increased in nephrotic patients insufficiently to replace urinary losses
Risk of suicidality with GLP-1 drugs
Eggs are nutrient powerhouses packed with protein, B vitamins, and choline, supporting liver and brain health
Targeted protection of mitochondrial function by nanoparticles Mitochondrial dysfunction is a key pathological mechanism in the process of RIRI, primarily involving abnormalities in the ETC, excessive ROS production, and disruption of mitochondrial membrane structure